Trexquant Investment LP Acquires New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Trexquant Investment LP bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 437,971 shares of the company's stock, valued at approximately $10,161,000. Trexquant Investment LP owned approximately 0.26% of Option Care Health as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp bought a new stake in shares of Option Care Health in the fourth quarter worth $26,000. UMB Bank n.a. grew its holdings in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC increased its position in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quarry LP increased its holdings in shares of Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after acquiring an additional 2,628 shares during the last quarter. Finally, Blue Trust Inc. lifted its stake in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after purchasing an additional 681 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on OPCH shares. JMP Securities reiterated a "market outperform" rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Barrington Research lifted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.

Remove Ads

Option Care Health Stock Down 2.3 %

Shares of NASDAQ:OPCH traded down $0.77 during trading on Monday, reaching $32.77. 786,710 shares of the company traded hands, compared to its average volume of 1,730,504. The firm has a fifty day simple moving average of $32.97 and a 200 day simple moving average of $28.49. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The firm has a market cap of $5.38 billion, a P/E ratio of 27.45, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.